bindarit has been researched along with Pericementitis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cao, J; Hu, W; Jiang, W; Li, N; Li, Q; Li, S; Liu, Z; Lv, P; Mo, Y; Song, Z; Wang, C; Wang, X; Wang, Y; Wei, Y; Xu, T; Yang, G; Yuan, S; Zhang, Y | 1 |
| Chen, J; Guan, M; Huang, X; Kuang, S; Lin, Z; Qin, W; Shen, Z; Xu, HHK; Zhang, M | 1 |
2 other study(ies) available for bindarit and Pericementitis
| Article | Year |
|---|---|
CCL2 is a key regulator and therapeutic target for periodontitis.
Topics: Animals; Chemokine CCL2; Chemokines; Humans; Ligands; Mice; Mice, Inbred C57BL; Periodontitis; X-Ray Microtomography | 2023 |
Inhibition of CCL2 by bindarit alleviates diabetes-associated periodontitis by suppressing inflammatory monocyte infiltration and altering macrophage properties.
Topics: Chemokine CCL2; Diabetes Mellitus; Humans; Indazoles; Macrophages; Monocytes; Periodontitis; Propionates | 2021 |